TLDR

TLDR 2025-09-09

6 sections20 entrieslinks blockcomplete parse

Parse notes

  • Subscription/account footer truncated before parsefooter_truncated

01GENERAL

02BIG TECH & STARTUPS

SPACEX'S $17 BILLION DEAL PLUNGES MUSK DEEPER INTO WIRELESS MARKET

SpaceX is paying $17 billion for the rights to use some of EchoStar's spectrum for cellphone service. The deal gives SpaceX access to two license blocks that allow carriers to provide ground-based 5G cellphone and broadband service in the US. The spectrum will be used as a foundation for Starlink's direct-to-cell business and may be shared with telecom partners. EchoStar will use the funds to retire debt and fund operations.

links.tldrnewsletter.com4 min read

INSIDE SPOTIFY'S PLOT TO TAKE DOWN APPLE

Apple's position as a gateway to the digital world is being severely imperiled by efforts from rival tech companies like Epic Games and Spotify. The EU Commission leveled a $2 billion fine against Apple for conduct against Spotify and others in March last year and introduced new laws to limit Apple's control over the App Store. These moves are being copied in other parts of the world, putting billions of dollars of profit at risk. The uncertainty comes at a time when iPhone sales are under pressure and investors are worried that Apple is failing to keep up with AI innovations.

links.tldrnewsletter.com13 min read

03SCIENCE & FUTURISTIC TECHNOLOGY

'NEAR TELEPATHIC' WEARABLE LETS YOU COMMUNICATE SILENTLY WITH DEVICES

Boston startup AlterEgo has unveiled a wearable that lets users silently communicate with machines using subvocal speech. The machine decodes neuromuscular signals in the jaw and throat, translating the signals with high accuracy. AlterEgo has positioned the device as a practical alternative to brain implants or EMG wristbands. A video from AlterEgo introducing the technology is available in the article.

decrypt.co3 min read

TAKEDA NEARS FIRST THERAPY FOR ROOT CAUSE OF NARCOLEPSY

Takeda Pharmaceutical has developed a drug that significantly improves outcomes for narcoleptic patients. The drug, called oveporexton, could become the first treatment to target the root cause of the chronic sleep disorder. Patients who take the drug experience increased daytime alertness, fewer episodes of sudden muscle tone loss, and overall improvement in quality of life. No serious side effects have been reported, but some patients report insomnia and increased urinary urgency and frequency. The company plans to file for regulatory approvals globally by March.

japantimes.co.jp3 min read

04PROGRAMMING, DESIGN & DATA SCIENCE

THE LAST PROGRAMMERS

We're the last generation of people who will translate ideas into code by hand. Future developers will just describe what they want and have it appear on the screen. The money and talent flowing into AI development make this future inevitable. The question is whether you'll be ready when it comes. Focus on the parts of product development that actually matter - understanding people, building the things they want, and getting those things in front of them.

xipu.li11 min read

SKIP TO THE END

For the first 75 years of computing, database lookups were trivial, and computer vision was virtually impossible. Today, you can just take a pick on your phone and ask it questions about the image. To really take advantage of what AI can do, developers need to start thinking about software differently. Tools no longer need to help users achieve outcomes - they just deliver the outcomes.

thenanyu.com2 min read

05MISCELLANEOUS

OUR DATA SHOWS SAN FRANCISCO TECH WORKERS ARE WORKING SATURDAYS

996 is a demanding work schedule that calls for working 9 AM to 9 PM, six days a week. Spending data shows that San Francisco-based employees are increasingly working on the schedule. The pattern is happening across industries, not just in tech.

ramp.com3 min read

OPENAI EXECUTIVES RATTLED BY CAMPAIGNS TO DERAIL FOR-PROFIT RESTRUCTURING

OpenAI executives are reportedly growing concerned that increasing political scrutiny could impede its efforts to become a for-profit company and have discussed the option of moving out of the state. Attorneys general in California and Delaware are investigating OpenAI's proposed plan to restructure into a for-profit company. OpenAI could be sued for potentially breaking nonprofit law and may be required to pay a settlement as a condition for the restructure. Failing to restructure could be catastrophic for the startup.

links.tldrnewsletter.com8 min read